Diametric Capital’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-43,771
| Closed | -$328K | – | 475 |
|
|
2024
Q2 | $328K | Buy |
43,771
+21,001
| +92% | +$158K | 0.18% | 164 |
|
|
2024
Q1 | $227K | Sell |
22,770
-41,864
| -65% | -$417K | 0.13% | 224 |
|
|
2023
Q4 | $637K | Sell |
64,634
-71,697
| -53% | -$707K | 0.39% | 78 |
|
|
2023
Q3 | $1.04M | Buy |
136,331
+16,425
| +14% | +$126K | 0.44% | 56 |
|
|
2023
Q2 | $896K | Buy |
+119,906
| New | +$896K | 0.4% | 64 |
|
|
2022
Q3 | – | Sell |
-35,665
| Closed | -$290K | – | 325 |
|
|
2022
Q2 | $290K | Buy |
+35,665
| New | +$290K | 0.21% | 160 |
|